Rnf24-KO Mouse
一般名
Rnf24-KO
製品ID
S-KO-10281
背景情報
C57BL/6NCya
系統ID
KOCMP-51902-Rnf24-B6N-VA
状況
このマウス系統を論文で使用する場合は、「Rnf24-KO Mouse(カタログ番号S-KO-10281)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Rnf24-KO
系統ID
KOCMP-51902-Rnf24-B6N-VA
遺伝子名
製品ID
S-KO-10281
遺伝子別名
D2Ertd504e, 2810473M14Rik, 4930505A13Rik
遺伝子別名
C57BL/6NCya
NCBI ID
修正
Conventional knockout
染色体
Chr 2
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000059372
NCBIトランスクリプトID
NM_178607
ターゲット領域
Exon 2~6
有効領域の大きさ
~9.9 kb
遺伝子研究の概要
Rnf24, a membrane RING-H2 protein, has been shown to interact with the ankyrin-like repeat domain of TRPCs (transient receptor potential canonical channels). It is involved in the intracellular trafficking of TRPCs by interacting with them in the Golgi apparatus without affecting their activity [1]. Rnf24 may also be related to focal adhesion, as it was identified as a hub gene associated with focal adhesion in osteoporosis research. Its increased expression in monocytes was observed in both mouse and human blood samples, and anti-RNF24 was found to partially alleviate the progression of osteoporosis in mouse experiments [2].
In the context of pain-depression comorbidity, Rnf24 was identified as one of the five hub genes through bioinformatics analysis, suggesting its potential as a diagnostic and prognostic marker for patients with this comorbidity [3]. It was also among the differentially regulated genes in aged female skeletal muscle, indicating its possible role in sarcopenia-related processes [4]. In Parkinson's disease, Rnf24 was identified as a hub gene and was part of a 7-gene panel that could serve as a potential diagnostic signature [5]. In BRCA wild-type high-grade serous ovarian cancer, Rnf24 was in a ten-gene signature predictive of response to first-line chemotherapy and was defined as a cell-autonomous contributor to tumor resistance [6].
In summary, Rnf24 is involved in multiple biological processes and diseases. Its role in the intracellular trafficking of TRPCs, its association with osteoporosis, pain-depression comorbidity, sarcopenia, Parkinson's disease, and ovarian cancer highlights its importance. Research on Rnf24 using various models can help further understand its functions and potentially lead to new diagnostic and therapeutic strategies for these diseases.
References:
1. Lussier, Marc P, Lepage, Pascale K, Bousquet, Simon M, Boulay, Guylain. 2007. RNF24, a new TRPC interacting protein, causes the intracellular retention of TRPC. In Cell calcium, 43, 432-43. doi:. https://pubmed.ncbi.nlm.nih.gov/17850865/
2. Shi, Xiaojian, Fu, Qiang, Mao, Jianyu, Chen, Aimin, Lu, Nan. . Integration of single-cell and RNA-seq data to explore the role of focal adhesion-related genes in osteoporosis. In Journal of cellular and molecular medicine, 28, e18271. doi:10.1111/jcmm.18271. https://pubmed.ncbi.nlm.nih.gov/38534087/
3. Zhang, Tianyun, Geng, Menglu, Li, Xiaoke, Zhang, Huaxing, Zhang, Fan. 2024. Identification of Oxidative Stress-Related Biomarkers for Pain-Depression Comorbidity Based on Bioinformatics. In International journal of molecular sciences, 25, . doi:10.3390/ijms25158353. https://pubmed.ncbi.nlm.nih.gov/39125922/
4. Gharpure, Mohini, Chen, Jie, Nerella, Resheek, Adusumilli, Satish, Fulzele, Sadanand. 2023. Sex-specific alteration in human muscle transcriptome with age. In GeroScience, 45, 1303-1316. doi:10.1007/s11357-023-00795-5. https://pubmed.ncbi.nlm.nih.gov/37106281/
5. Wu, Zhaoping, Hu, Zhiping, Gao, Yunchun, Zhang, Xiaobo, Jiang, Zheng. 2023. A computational approach based on weighted gene co-expression network analysis for biomarkers analysis of Parkinson's disease and construction of diagnostic model. In Frontiers in computational neuroscience, 16, 1095676. doi:10.3389/fncom.2022.1095676. https://pubmed.ncbi.nlm.nih.gov/36704228/
6. Buttarelli, Marianna, Ciucci, Alessandra, Palluzzi, Fernando, Scambia, Giovanni, Gallo, Daniela. 2022. Identification of a novel gene signature predicting response to first-line chemotherapy in BRCA wild-type high-grade serous ovarian cancer patients. In Journal of experimental & clinical cancer research : CR, 41, 50. doi:10.1186/s13046-022-02265-w. https://pubmed.ncbi.nlm.nih.gov/35120576/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
